Del Carmen Jeffrey 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Del Carmen Jeffrey
Chief Commercial Officer
Transactions
- Sale
Common stock, par value $0.001 per share
2025-03-03$22.89/sh−30,423$696,382→ 0 total
Footnotes (1)
- [F1]Shares were sold for personal reasons and not as a result of any disagreement with the Company.